மருந்து வளர்ச்சி தலை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GT Apeiron Therapeutics Strengthens Advisory Board
News provided by
Share this article
Share this article
SHANGHAI, April 15, 2021 /PRNewswire/ Keith Lenden and Dr. Honggang Bi has been appointed as new members of the Advisory Board at GT Apeiron Therapeutics, an AI empowered drug discovery start-up developing oncology therapeutics. Mr. Lenden and Dr. Bi add further expertise in drug discovery innovation, translational medicine, and clinical development; and deep knowledge and perspectives from both USA and Asia-Pacific region, to the Company s Advisory Board.
Mr. Keith Lenden is a seasoned entrepreneur and leader in the biotechnology and pharmaceutical industries with a proven track record in company formation, executive and project leadership, corporate development and product and market strategy. Mr. Lenden is a Venture Partner at ARCH Venture Partners and a co-founder of Autobahn Therapeutics, Boundless Bio, Receptos (acquired by Celgene), and Abide Ther ....

United States , Smithkline Beecham , Keith Lenden , Prnewswire Keith Lenden , Drug Development Head , Company Advisory Board , Advisory Board , Venture Partner , Autobahn Therapeutics , Boundless Bio , Abide Therapeutics , Senior Vice President , General Manager China , ஒன்றுபட்டது மாநிலங்களில் , ஸ்மித்‌க்லைந் பீச்சம் , மருந்து வளர்ச்சி தலை , துணிகர கூட்டாளர் , ஆட்டோபான் சிகிச்சை , எல்லையற்ற உயிர் , ஒத்துப்போ சிகிச்சை , மூத்தவர் துணை ப்ரெஸிடெஂட் , ஜநரல் மேலாளர் சீனா ,